In March 2023, Pfizer made a major move by acquiring Seagen, a global leader in antibody-drug conjugates (ADCs), for USD 43 billion. This acquisition strengthens Pfizer's oncology portfolio and positions them as a leading force in cancer treatment.
In 2023, Pfizer invested in ResApp Health, a company developing AI-powered tools for diagnosing respiratory diseases like pneumonia and tuberculosis using smartphone recordings. This partnership aims to improve access to accurate and affordable diagnosis in low- and middle-income countries where these diseases are prevalent.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5504
Published Date: Jan 05, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing demand for healthcare sector is the major factor driving the market growth.
The market size of liquid pediatric is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.
The major players in the market Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc., and others.
The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.